Healthcare & Life Sciences
Astrocyte
series-a
series-a
Stage
2
Investors
About
Astrocyte develops small-molecule cerebroprotectants aimed at treating concussion, traumatic brain injury, and stroke.
Explore Astrocyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.